Bioactive Isolates of Morus Species as Antibacterial Agents and their in-silico Profiling

(E-pub Ahead of Print)

Author(s): Aditya Rao*, Venugopal T.M, Jayanna N.D, Paramesha Mahadevappa, Ramesh C.K

Journal Name: Letters in Drug Design & Discovery

Become EABM
Become Reviewer
Call for Editor


Background: The genus Morus is one of the rich sources of phytomedicine and considered as a beneficial natural source for the drugs with potential antimicrobial effect under the traditional system of medicine.

Introduction: In the present study, three bioactive compounds were isolated from the leaves of two species of genus Morus and their antibacterial effect against selective pathogens were assessed.

Methods: The inhibitory effects of the three molecules isolated were assessed for their minimum inhibition concentration (MIC) and minimum bactericidal concentration (MBC) against selected pathogens. The in-silico studies provided the toxicity profile and the binding interactions with glucosamine-6-phosphate synthase for all the isolates.

Results and Discussion: Among the three compounds tested, cathafuran-B showed prominent bacteriostatic and bactericidal effect which is supported by the results of in-silico analysis suggesting cathafuran-B could be a potential glucosamine-6- phosphate synthase inhibitor.

Conclusion: The biomolecule isolated from less explored Morus laevigata exhibiting higher antibacterial effect among the compounds tested warranted opening a new prospect in phytomedicinal research in exploring its pharmacological properties and lowering the utilization load present on highly explored Morus alba.

Keywords: Bacteriostatic, Docking, Natural products, CHARMm, Glucosamine-6-phosphate synthase, Morus.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1570180817999201104120815
Price: $95

Article Metrics

PDF: 1